Background: The human APOBEC3G (A3G) protein activity is associated with innate immunity against HIV-1 by inducing high rates of guanosines to adenosines (G-to-A) mutations (viz., hypermutation) in the viral DNA. If hypermutation is not enough to disrupt the reading frames of viral genes, it may likely increase the HIV-1 diversity. To counteract host innate immunity HIV-1 encodes the Vif protein that binds A3G protein and form complexes to be degraded by cellular proteolysis.
Methods: Here we studied the pattern of substitutions in the vif gene and its association with clinical status of HIV-1 infected individuals. To perform the study, unique vif gene sequences were generated from 400 antiretroviral-naïve individuals.
Results: The codon pairs: 78-154, 85-154, 101-157, 105-157, and 105-176 of vif gene were associated with CD4+ T cell count lower than 500 cells per mm(3). Some of these codons were located in the (81)LGQGVSIEW(89) region and within the BC-Box. We also identified codons under positive selection clustered in the N-terminal region of Vif protein, between (21)WKSLVK(26) and (40)YRHHY(44) regions (i.e., 31, 33, 37, 39), within the BC-Box (i.e., 155, 159) and the Cullin5-Box (i.e., 168) of vif gene. All these regions are involved in the Vif-induced degradation of A3G/F complexes and the N-terminal of Vif protein binds to viral and cellular RNA.
Conclusions: Adaptive evolution of vif gene was mostly to optimize viral RNA binding and A3G/F recognition. Additionally, since there is not a fully resolved structure of the Vif protein, codon pairs associated with CD4+ T cell count may elucidate key regions that interact with host cell factors. Here we identified and discriminated codons under positive selection and codons under functional constraint in the vif gene of HIV-1.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637627 | PMC |
| http://dx.doi.org/10.1186/1471-2334-13-173 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction: HIV-1 non-structural proteins are promising targets for vaccine development and for creating approaches to personalized medicine. HIV-1 sub-subtype A6 has become the dominating strain in Russia. However, the geographic, economic and demographic characteristics of the country can contribute to the formation of differences between A6 variants circulating in different regions.
View Article and Find Full Text PDFAcute-phase innate immune responses in SIVmac239-infected Indian rhesus macaques may contribute to the establishment of elite control.
Front Immunol
November 2024
Department of Immunology, Center for Innate Immunity and Immune Disease, School of Medicine, University of Washington, Seattle, WA, United States.
Article Synopsis
- The study investigates the spontaneous control of HIV/SIV viremia and its association with specific MHC class I allotypes, emphasizing the importance of CD8+ cytotoxic T lymphocytes (CTLs) for managing viral loads.
- Researchers aimed to understand the factors contributing to a phenotype known as elite controllers (ECs) by vaccinating rhesus macaques and analyzing immune responses after infection.
- Results showed that while vaccination did not prevent infection, it led to lower viral levels in vaccinated macaques, and 81% of them achieved elite control, highlighting differences in immune gene expression between vaccinated and unvaccinated groups.
The association between HIV-1 Tat and Vif amino acid sequence variation, inflammation and Trp-Kyn metabolism: an exploratory investigation.
BMC Infect Dis
September 2024
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Background: HIV-1 has well-established mechanisms to disrupt essential pathways in people with HIV, such as inflammation and metabolism. Moreover, diversity of the amino acid sequences in fundamental HIV-1 proteins including Tat and Vif, have been linked to dysregulating these pathways, and subsequently influencing clinical outcomes in people with HIV. However, the relationship between Tat and Vif amino acid sequence variation and specific immune markers and metabolites of the tryptophan-kynurenine (Trp-Kyn) pathway remains unclear.
View Article and Find Full Text PDFPredictive biomarkers for embryotoxicity: a machine learning approach to mitigating multicollinearity in RNA-Seq.
Arch Toxicol
December 2024
Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Article Synopsis
- The study investigates the issue of multicollinearity among genes in high-throughput RNA-Seq data, which can affect the reliability of predictive models.
- Six genes associated with embryotoxicity were identified and validated using qPCR after being exposed to various substances, with Zfp42 and Hoxb1 highlighted as potential early biomarkers.
- The researchers implemented a systematic methodology combining machine learning and statistical analyses, successfully reducing redundancies and improving predictive accuracy, ultimately benefiting embryotoxicity screening research.
Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1.
Bioorg Med Chem Lett
October 2024
State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Sichuan, Chengdu 610041, China. Electronic address:
Article Synopsis
- Viral infectivity factor (Vif) is a promising target for HIV-1 treatments, and researchers have developed a new class of inhibitors that work well against HIV-1 and its drug-resistant strains.
- Using proteolytic targeting chimera (PROTAC), the study explores how to effectively degrade the Vif protein, which is crucial for the virus's ability to replicate.
- The compound L15 has shown a dose-dependent ability to degrade Vif and demonstrated antiviral activity, laying the groundwork for future antiviral drug development using PROTACs for HIV/AIDS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!